Genotype-phenotype relationship in 12 patients carrying cystic fibrosis mutation R334W

Journal of Medical Genetics

Volumn 34, Issue 2, 1997, Pages 89-91

  Antiñolo, Guillermo ^a   Borrego, Salud ^a   Gili, Miguel ^a   Dapena, Javier ^a   Alfageme, Inmaculada ^b   Reina, Francisco ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b HOSPITAL UNIVERSITARIO DE VALME   (Spain)

Author keywords

Cystic fibrosis; Genotype phenotype correlation; R334W mutation

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BACTERIAL COLONIZATION; BODY WEIGHT; CHILD; CLINICAL ARTICLE; CYSTIC FIBROSIS; FEMALE; GENE MUTATION; GENOTYPE; HEIGHT; HETEROZYGOTE; HUMAN; HUMAN CELL; MALE; ONSET AGE; PANCREAS INSUFFICIENCY; PHENOTYPE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STATISTICAL ANALYSIS;

BACTERIA (MICROORGANISMS); PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 0031040853     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.34.2.89     Document Type: Article

References (15)

1. Kerem BS, Rommens JM, Buchanan JA, et al. Identification of the cystic fibrosis gene: genetic analysis. Science 1989;245:1073-80.
2. Kerem E, Corey M, Kerem BS, et al. The relation between genotype and phenotype in cystic fibrosis: analysis of the most common mutation (AF508). N Engl J Med 1990;323: 1517-22.
3. Dalemans W, Barbry P, Champigny G, et al. Altered chloride ion channel kinetics associated with the AF508 cystic fibrosis mutation. Nature 1991;354:526-8.
4. Rommens JM, Dho S, Bear CE, et al. cAMP-inducible chloride conductance in mouse fibroblast line stably expressing the human cystic fibrosis transmembrane conductance regulator. Proc Natl Acad Sci USA 1991;88:7500-4.
5. Bear EC, Li C, Karner N, et al. Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR). Cell 1992;68:809-18.
6. The Cystic Fibrosis Analysis Consortium. Population variation of common CF mutations. Hum Mutat 1994;4:167-77.
7. Gasparini P, Nunes V, Savoia A, et al. The search for south European cystic fibrosis mutations: identification of two new mutations, four variants and intronic sequences. Genomia 1991;10:193-200.
8. Borrego S, Casals T, Dapena J, et al. Molecular and clinical analyses of cystic fibrosis in the south of Spain. Clin Genet 1994;46:287-90.
9. Mortal N, Estivill X. Multiplex PCR amplification of three microsatellites within the CFTR gene. Genomics 1992;13: 1362-4.
10. Van der Kamer JH, ten Bokkel Huinink H, Weyers HA. Rapid method for the determination of fat in faeces. J Biol Chem 1949;117:347-55.
11. BMDP Statistical Software Manual (2 volumes). Berkeley: University of California Press, 1994.
12. Welsh MJ, Smith AE. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell 1993;73:1251-4.
13. Morral N, Llevadot R, Casals T, et al. Independent origins of cystic fibrosis mutations R334W, R347P, R1162X, and 3849+10kbCT provide evidence of mutation recurrence in the CFTR gene. Am J Hum Genet 1994;55:890-8.
14. Estivill X, Ortigosa L, Perez-Frias J, et al. Clinical characteristics of 16 cystic fibrosis patients with the missense mutation R334W, a pancreatic insufficiency mutation with variable age of onset and interfamilial clinical differences. Hum Genet 1995;95:331-6.
15. Rozmahel R, Wilchansk M, Matin A, et al. Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor. Nat Genet 1996;12:280-7.